Clinical trials in Herning – page 6

133 clinical trials in Herning, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in DenmarkKliniske-Forsoeg.dk

Herning at a glance

133

clinical trials

Research sites1

Quick filters

133 trials in Herning

Open in trial search

HIV infection

Not yet recruiting

Durable HIV-1 control with 10-1074-LS, 3BNC117-LS and nivolumab in adults on ART: a randomized double‑blind placebo‑controlled trial

Registered drug

Durable HIV-1 control with 10-1074-LS, 3BNC117-LS and nivolumab in adults on ART: a randomized double‑blind placebo‑controlled trial

Registered drug

Denmark

Participants:18–64 years
Substances:Nivolumab
Sponsor:Region Midtjylland

Contact Research Centre

Cardiovascular disorder

Not yet recruiting

Rosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care

Registered drug

Rosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Rosuvastatin Zinc
Sponsor:Copenhagen University Hospital

Contact Research Centre

Colon cancer

Not yet recruiting

Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

Registered drugNo placebo

Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Region Sjaelland

Contact Research Centre

Polymyalgia rheumatica

Not yet recruiting

A study to evaluate the safety and effectiveness of resomelagon in patients with polymyalgia rheumatica who are in remission using glucocorticoids

Investigational

A study to evaluate the safety and effectiveness of resomelagon in patients with polymyalgia rheumatica who are in remission using glucocorticoids

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Resomelagon
Sponsor:Synact Pharma ApS

Contact Research Centre

Type 1 diabetes mellitus+1

Not yet recruiting

A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

Registered drugNo placebo

A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

Registered drugNo placebo

Denmark

Participants:18–64 years
Substances:Dapagliflozin
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

K-ras gene mutation+2

Not yet recruiting

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Registered drugNo placebo

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Budesonide
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Varicella

Not yet recruiting

Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children

Registered drugNo placebo

Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children

Registered drugNo placebo

Denmark

Participants:0–17 years · Healthy volunteers
Substances:GSKVX000000025896
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Nephrolithiasis

Not yet recruiting

Evaluation of tamsulosin and furosemide combination therapy after shock wave lithotripsy in patients with kidney stones

Registered drugNo placebo

Evaluation of tamsulosin and furosemide combination therapy after shock wave lithotripsy in patients with kidney stones

Registered drugNo placebo

Denmark

Participants:18–64 years
Substances:Furosemide
Sponsor:Region Midtjylland

Contact Research Centre

Nephrolithiasis

Not yet recruiting

Study of tamsulosin and furosemide combination therapy for patients after shock wave lithotripsy of kidney stones

Registered drugNo placebo

Study of tamsulosin and furosemide combination therapy for patients after shock wave lithotripsy of kidney stones

Registered drugNo placebo

Denmark

Participants:18–64 years
Substances:Furosemide
Sponsor:Region Midtjylland

Contact Research Centre

Type IIa hyperlipidaemia

Not yet recruiting

Study on MK-0616 for Reducing Heart Disease Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational

Study on MK-0616 for Reducing Heart Disease Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:MK-0616
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Relapsing multiple sclerosis+2

Not yet recruiting

Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

Registered drug

Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Teriflunomide
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not yet recruiting

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo

Denmark

Participants:65+ years
Substances:Cyclophosphamide
Sponsor:Region Skane

Contact Research Centre

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Herning

What the registry says about research in the country

01 Immunology and Vaccines

Clinical trials focusing on preventive vaccines for various conditions including meningococcal disease, chickenpox, and respiratory syncytial virus. Studies evaluate safety profiles and immune responses in different age groups.

Meningococcal Pentavalent Vaccine
Varicella Prevention
RSV Protection in Infants

Research emphasizes vaccine safety and immunogenicity in vulnerable populations.

02 Cardiovascular Research

Innovative studies addressing heart failure prevention and cardiovascular outcomes in high-risk patients. Trials examine new therapeutic combinations and preventive strategies.

Heart Failure Prevention
ASCVD Management
Post-Stroke Care

Focus on reducing major adverse cardiovascular events through novel treatment approaches.

03 Nephrology and Transplantation

Studies exploring treatments for chronic kidney disease and transplant recipients, investigating new therapeutic options and medication effectiveness.

Kidney Transplant Care
CKD Management
Diabetic Nephropathy

Research aims to improve outcomes in kidney disease and transplantation.

Back to Denmark All countries